All securities issued in connection with the Offering and the Concurrent Private Placement are subject to a statutory hold period expiring four months and one day after December 7, 2017.
have never seen this time period anywhere before -must be some canadian time period equiv to the 6 month usa time period for SEC filers
so those pp holders HOLDING SHARES AT 1.15 PPS COULD SELL AS EARLY AS April 8 assuming that was a trading day
but the promoters often sell earlier
The Offering was underwritten by Cormark Securities Inc. (the “Underwriter”), which exercised in full its option to purchase up to an additional 500,000 Units at the Offering Price.
In connection with the Offering, the Underwriter received a cash commission of $276,000 and 240,000 broker warrants (the “Broker Warrants”), each Broker Warrant entitling the holder to purchase one Unit at the Offering Price for a period of two years following closing.
these promoters-underwriters- are another flag on the play -until they sell all of their received 'free' shares-in the usa promoters who receive shares like this have to file S-1 reg statements w the SEC
In addition, the Company is pleased to announce that it has closed a concurrent non-brokered private placement (the “Concurrent Private Placement”) of 850,000 units at the Offering Price, for aggregate gross proceeds of $977,500. The units issued pursuant to the Concurrent Private Placement were issued on substantially the same terms as the Units issued under the Offering.
The Company intends to use the net proceeds from the Offering and the Concurrent Private Placement to fund research and development related to its cannabis breathalyzer technologies and for working capital and general corporate purposes.
All securities issued in connection with the Offering and the Concurrent Private Placement are subject to a statutory hold period expiring four months and one day after December 7, 2017.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state laws and may not be offered or sold in the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or unless an exemption from such registration is available.
Not For Distribution To U.S. Newswire Services Or Dissemination In The United States.
November 17, 2017
Cannabix Technologies Inc. Announces Upsize of Previously Announced Bought Deal Private Placement to and Concurrent Non-Brokered Private Placement
have never seen this time period anywhere before -must be some canadian time period equiv to the 6 month usa time period for SEC filers
so those pp holders HOLDING SHARES AT 1.15 PPS COULD SELL AS EARLY AS April 8 assuming that was a trading day
but the promoters often sell earlier
The Offering was underwritten by Cormark Securities Inc. (the “Underwriter”), which exercised in full its option to purchase up to an additional 500,000 Units at the Offering Price.
In connection with the Offering, the Underwriter received a cash commission of $276,000 and 240,000 broker warrants (the “Broker Warrants”), each Broker Warrant entitling the holder to purchase one Unit at the Offering Price for a period of two years following closing.
these promoters-underwriters- are another flag on the play -until they sell all of their received 'free' shares-in the usa promoters who receive shares like this have to file S-1 reg statements w the SEC
In addition, the Company is pleased to announce that it has closed a concurrent non-brokered private placement (the “Concurrent Private Placement”) of 850,000 units at the Offering Price, for aggregate gross proceeds of $977,500. The units issued pursuant to the Concurrent Private Placement were issued on substantially the same terms as the Units issued under the Offering.
The Company intends to use the net proceeds from the Offering and the Concurrent Private Placement to fund research and development related to its cannabis breathalyzer technologies and for working capital and general corporate purposes.
All securities issued in connection with the Offering and the Concurrent Private Placement are subject to a statutory hold period expiring four months and one day after December 7, 2017.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state laws and may not be offered or sold in the United States or to U.S. persons unless registered under the U.S. Securities Act and applicable state securities laws or unless an exemption from such registration is available.
Not For Distribution To U.S. Newswire Services Or Dissemination In The United States.
November 17, 2017
Cannabix Technologies Inc. Announces Upsize of Previously Announced Bought Deal Private Placement to and Concurrent Non-Brokered Private Placement
1
